FDA approves ArteFill for treatment of nasolabial folds

November 7, 2006

Washington-The Food and Drug Administration has approved ArteFill for use in correcting nasolabial folds.

Washington-The Food and Drug Administration has approved ArteFill for use in correcting nasolabial folds.

A statement released by San Diego-based manufacturer Artes Medical says ArteFill differs from other fillers because while they are completely metabolized by the body, ArteFill’s non-resorbability provides a permanent support structure for long-term wrinkle correction.

“Artefill represents the first FDA-approved filler with the ability to last significantly longer than the products we have had in the past,” Mark G. Rubin, M.D., assistant clinical professor of dermatology at the University of California, San Diego, and a Beverly Hills dermatologist, tells Dermatology Times. “What the impact of this product will be on the dermal filler market remains to be seen. It certainly offers physicians a significantly different option in a filler product-and the more options we have to treat patients, the better the results we will be able to achieve.”

Artefill is made of a combination of polymethylmethacrylate (PMMA) microspheres suspended in a carrier gel containing purified bovine collagen.